Heterocyclic inhibitors of the sodium channel
AssigneeMark G. DeGiacomo
InventorsGlenn F. Short, III, Donna L. Romero, Margaret S. Lee
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds useful in treating conditions associated with voltage-gated ion channel function, particularly conditions associated with sodium channel activity. More specifically, the invention concerns heterocyclic compounds (e.g., compounds according to any of Formulas (I)-(III) or Compounds (1)-(65) of Table 1) that are that are useful in treatment of conditions such as epilepsy, cancer, pain, migraine, Parkinson's Disease, mood disorders, schizophrenia, psychosis, tinnitus, amyotropic lateral sclerosis, glaucoma, ischaemia, spasticity disorders, obsessive compulsive disorder, restless leg syndrome and Tourette syndrome.
Claims2
A compound having a structure according to the following formula,
- or a stereoisomer thereof;
- or a pharmaceutically acceptable salt thereof, wherein
- R1 and R2 are CF3;
- R3 and R4 are independently H, a halogen, or a nitrile;
- R5 is a monocyclic ring substituted with at least two substituents selected from the group consisting H, a halogen, —NH2, —SO2NHPh, methyl, or hydroxyl;
- and Y2 is —NHCO;
- n is 1.
Dependencies are inferred from the claim text.